Transaction in Own Shares

Summary by AI BETAClose X

RTW Biotech Opportunities Ltd announced a share buyback on November 26, 2025, repurchasing 100,000 Ordinary Shares at $1.92 per share. Following this transaction, the company's issued Ordinary Share capital stands at 345,967,440, with 19,243,791 shares held in treasury, resulting in a total of 326,723,649 voting rights. This buyback was authorized by shareholders at the June 2025 Annual General Meeting and is intended to be held in treasury, with no premium to net asset value paid.

Disclaimer*

UK 100

Latest directors dealings